BGI Genomics Co Ltd (300676)

Currency in CNY
39.94
-0.36(-0.89%)
Closed·
300676 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
39.8340.50
52 wk Range
38.1765.00
Key Statistics
Bid/Ask
39.93 / 39.94
Prev. Close
40.3
Open
40.33
Day's Range
39.83-40.5
52 wk Range
38.17-65
Volume
4.79M
Average Volume (3m)
5.38M
1-Year Change
-15.425%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300676 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
57.72
Upside
+44.52%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

BGI Genomics Co Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 57.72
(+44.52% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Apr 25, 2026
EPS / Forecast
-0.02 / --
Revenue / Forecast
809M / --
EPS Revisions
Last 90 days

300676 Income Statement

Compare 300676 to Peers and Sector

Metrics to compare
300676
Peers
Sector
Relationship
P/E Ratio
−26.7x−3.9x−0.5x
PEG Ratio
−0.650.050.00
Price/Book
1.8x3.6x2.6x
Price / LTM Sales
4.0x6.7x3.2x
Upside (Analyst Target)
20.9%37.9%48.8%
Fair Value Upside
Unlock5.1%6.9%Unlock

BGI Genomics Co., Ltd. engages in the provision of research services, comprehensive precision medicine testing solutions, and health management services in China and internationally. The company offers DNA sequencing services comprising plant/animal/microbial whole genome re-sequencing and de novo sequencing; human whole genome sequencing, long-read human whole genome resequencing, and whole exome sequencing; epigenetics whole genome bisulfite sequencing and ChIp-Seq; and metagenomics and 16S/18S/ITS sequencing. It also provides RNA sequencing, long non-coding RNA sequencing, small RNA sequencing, iso-seq / pacbio transcriptome sequencing; single cell sequencing and high throughput single cell RNA-Seq; spatial transcriptome-stereo-seq; immune repertoire and pre-made library sequencing; and bioinformatics solutions.In addition, the company offers mass spectrometry, including proteomics, metabolomics, and multi-omics. Further, it provides clinical solutions for reproductive health, oncology, infectious disease, and chronic disease. The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. The company was founded in 1999 and is headquartered in Shenzhen, China. BGI Genomics Co., Ltd. operates as a subsidiary of BGI Group.

Employees
3580
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
41.06M10.70%1.65B
Other Institutional Investors
171.58M44.70%6.91B
Public Companies & Retail Investors
171.21M44.60%6.90B
Total
383.85M100.00%15.47B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Shenzhen Huada Gene Technology Co., Ltd.33.47%128,488,7345,131,840
Shenzhen Qianhai BGI Investment Enterprise (Limited Partnership)7.73%29,665,1541,184,826

People Also Watch

53.88
600276
-2.02%
38.64
603288
-1.60%
58.87
600660
-0.89%
173.30
688008
+2.00%
10.78
300015
-1.55%

FAQ

What Is the BGI Genomics (300676) Stock Price Today?

The BGI Genomics stock price today is 39.94 CNY.

What Stock Exchange Does BGI Genomics Trade On?

BGI Genomics is listed and trades on the Shenzhen Stock Exchange.

What Is the Stock Symbol for BGI Genomics?

The stock symbol for BGI Genomics is "300676."

What Is the BGI Genomics Market Cap?

As of today, BGI Genomics market cap is 15.33B CNY.

What Is BGI Genomics's Earnings Per Share (TTM)?

The BGI Genomics EPS (TTM) is -1.37.

When Is the Next BGI Genomics Earnings Date?

BGI Genomics will release its next earnings report on Apr 27, 2026.

From a Technical Analysis Perspective, Is 300676 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BGI Genomics Stock Split?

BGI Genomics has split 0 times.

How Many Employees Does BGI Genomics Have?

BGI Genomics has 3580 employees.

What is the current trading status of BGI Genomics (300676)?

As of May 01, 2026, BGI Genomics (300676) is trading at a price of 39.94 CNY, with a previous close of 40.30 CNY. The stock has fluctuated within a day range of 39.83 CNY to 40.50 CNY, while its 52-week range spans from 38.17 CNY to 65.00 CNY.

What Is BGI Genomics (300676) Price Target According to Analysts?

The average 12-month price target for BGI Genomics is 57.72 CNY, with a high estimate of 57.72 CNY and a low estimate of 57.72 CNY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +44.52% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.